Cite
Würfel F, Erber R, Huebner H, et al. TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes. Breast Care (Basel). 2018;13(1):8-14doi: 10.1159/000486949.
Würfel, F., Erber, R., Huebner, H., Hein, A., Lux, M. P., Jud, S., Kremer, A., Kranich, H., Mackensen, A., Häberle, L., Hack, C. C., Rauh, C., Wunderle, M., Gaß, P., Rabizadeh, S., Brandl, A. L., Langemann, H., Volz, B., Nabieva, N., Schulz-Wendtland, R., Dudziak, D., Beckmann, M. W., Hartmann, A., Fasching, P. A., & Rübner, M. (2018). TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes. Breast care (Basel, Switzerland), 13(1), 8-14. https://doi.org/10.1159/000486949
Würfel, Franziska, et al. "TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes." Breast care (Basel, Switzerland) vol. 13,1 (2018): 8-14. doi: https://doi.org/10.1159/000486949
Würfel F, Erber R, Huebner H, Hein A, Lux MP, Jud S, Kremer A, Kranich H, Mackensen A, Häberle L, Hack CC, Rauh C, Wunderle M, Gaß P, Rabizadeh S, Brandl AL, Langemann H, Volz B, Nabieva N, Schulz-Wendtland R, Dudziak D, Beckmann MW, Hartmann A, Fasching PA, Rübner M. TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes. Breast Care (Basel). 2018 Mar;13(1):8-14. doi: 10.1159/000486949. Epub 2018 Feb 15. PMID: 29950961; PMCID: PMC6016056.
Copy
Download .nbib